A Concise History of Thiopurines for Inflammatory Bowel Disease: From Anecdotal Reporting to Treat-to-Target Algorithms

Author:

Actis Giovanni Clemente1,Pellicano Rinaldo2,Ribaldone Davide Giuseppe3

Affiliation:

1. The Medical Center Practice Office, Turin, Italy

2. Unit of Gastroenterology, Molinette Hospital, Turin, Italy

3. Department of Medical Sciences, University of Turin, Turin, Italy

Abstract

Background:The need for immune suppressive strategies in the control of chronic inflammatory bowel diseases originated in the 1960s following the perception of a relative inefficacy of salazopyrin and its derivatives. In some 50 years upon an anecdotal claim, the indication for thiopurines in the management of inflammatory bowel diseases has come of age.Objective:The aim of this minireview is to give an overview, after the historical premises, of the current use of thiopurines in the context of inflammatory bowel diseases.Method:Through MEDLINE searches, we reviewed the literature of the last two decades.Results:For Crohn’s disease, the 1980 trial of 6-mercaptopurine for steroid sparing and fistula closure proved pivotal. The analysis of withdrawal experiments and of numerous open trials has established the efficacy of thiopurines for ulcerative colitis. In this indication, cutting-edge data are now showing that because targeting dysplasia, thiopurines can induce mucosal/histological healing, thus abolishing or delaying the need for pre-emptive (tumor prophylactic) colectomy.Conclusion:In UC thiopurines may be recognized to effect a treat-to-target strategy, joining the modern algorithms of rheumatologic disorders.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,General Medicine

Reference57 articles.

1. Aller MA, Arias N, Fuentes-Julian S. Coupling inflammation with evo-devo.

2. Malekzadeh MM, Vahedi H, Gohari K. Emerging epidemic of inflammatory bowel disease in a middle income country: A nation-wide study from Iran.

3. Holleran G, Lopetuso LR, Ianiro G. Gut microbiota and inflammatory bowel disease: So far so gut!

4. Watkinson G. Sulphasalazine: A review of 40 years’ experience.

5. Li W, Zhang ZM, Jiang XL. Once daily multiple daily mesalamine therapy for mild-to-moderate ulcerative colitis: A meta-analysis.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3